86 related articles for article (PubMed ID: 22760311)
1. In-cell NMR in mammalian cells: part 1.
Bekei B; Rose HM; Herzig M; Dose A; Schwarzer D; Selenko P
Methods Mol Biol; 2012; 895():43-54. PubMed ID: 22760311
[TBL] [Abstract][Full Text] [Related]
2. In-cell NMR in mammalian cells: part 2.
Bekei B; Rose HM; Herzig M; Selenko P
Methods Mol Biol; 2012; 895():55-66. PubMed ID: 22760312
[TBL] [Abstract][Full Text] [Related]
3. In-cell NMR in mammalian cells: part 3.
Bekei B; Rose HM; Herzig M; Stephanowitz H; Krause E; Selenko P
Methods Mol Biol; 2012; 895():67-83. PubMed ID: 22760313
[TBL] [Abstract][Full Text] [Related]
4. In-cell NMR in Xenopus laevis oocytes.
Thongwichian R; Selenko P
Methods Mol Biol; 2012; 895():33-41. PubMed ID: 22760310
[TBL] [Abstract][Full Text] [Related]
5. Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?
Binolfi A; Theillet FX; Selenko P
Biochem Soc Trans; 2012 Oct; 40(5):950-4. PubMed ID: 22988846
[TBL] [Abstract][Full Text] [Related]
6. Single-molecule fluorescence studies of intrinsically disordered proteins.
Ferreon AC; Moran CR; Gambin Y; Deniz AA
Methods Enzymol; 2010; 472():179-204. PubMed ID: 20580965
[TBL] [Abstract][Full Text] [Related]
7. Structural disorder of monomeric α-synuclein persists in mammalian cells.
Theillet FX; Binolfi A; Bekei B; Martorana A; Rose HM; Stuiver M; Verzini S; Lorenz D; van Rossum M; Goldfarb D; Selenko P
Nature; 2016 Feb; 530(7588):45-50. PubMed ID: 26808899
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
9. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
[TBL] [Abstract][Full Text] [Related]
10. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
[TBL] [Abstract][Full Text] [Related]
11. Recording In-Cell NMR-Spectra in Living Mammalian Cells.
Matečko-Burmann I; Burmann BM
Methods Mol Biol; 2020; 2141():857-871. PubMed ID: 32696393
[TBL] [Abstract][Full Text] [Related]
12. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
13. Macromolecular crowding in the Escherichia coli periplasm maintains alpha-synuclein disorder.
McNulty BC; Young GB; Pielak GJ
J Mol Biol; 2006 Feb; 355(5):893-7. PubMed ID: 16343531
[TBL] [Abstract][Full Text] [Related]
14. MAP-mediated nuclear delivery of a cargo protein.
Kenien R; Zaro JL; Shen WC
J Drug Target; 2012 May; 20(4):329-37. PubMed ID: 22225540
[TBL] [Abstract][Full Text] [Related]
15. Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death.
Yamashita H; Nakamura T; Takahashi T; Nagano Y; Hiji M; Hirabayashi T; Amano T; Yagi T; Sakai N; Kohriyama T; Matsumoto M
J Neurochem; 2006 Jul; 98(1):45-56. PubMed ID: 16805795
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
17. In-Cell NMR of Intrinsically Disordered Proteins in Mammalian Cells.
Gerez JA; Prymaczok NC; Riek R
Methods Mol Biol; 2020; 2141():873-893. PubMed ID: 32696394
[TBL] [Abstract][Full Text] [Related]
18. 5-fluoro-D,L-tryptophan as a dual NMR and fluorescent probe of α-synuclein.
Pfefferkorn CM; Lee JC
Methods Mol Biol; 2012; 895():197-209. PubMed ID: 22760321
[TBL] [Abstract][Full Text] [Related]
19. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
Ma DX; Shi NQ; Qi XR
Int J Pharm; 2011 Oct; 419(1-2):200-8. PubMed ID: 21843610
[TBL] [Abstract][Full Text] [Related]
20. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
